-
AstraZeneca and Amgen get optimistic phase 3 asthma drug results — Pfizer/BioNTech begin studies for third booster dose and development of vaccine for variants — Merck KGaA in biobucks pact with Debiopharm for next-gen cancer asset See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
skinmedica... whats it like
Discussion in 'SkinMedica' started by Anonymous, Oct 25, 2006 at 7:59 AM.
Page 2 of 13
Page 2 of 13